The APEX COPD Registry has been registered and approved by the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) which is a network coordinated by the European Medicines Agency (EMA).
The European Union electronic Register of Post-Authorisation Studies (EU PAS Register) number for the APEX COPD Registry is EUPAS29401. Further information of the study is also listed publicly on the EU PAS Register.
The APEX COPD Registry has been approved by The American Academy of Family Physicians National Research Network (AAFP NRN) whose responsibilities are to conduct support, promote and advocate for primary care research in practice-based settings. The protocol approval number for the APEX COPD Registry is #19 – 349.
The APEX COPD Registry has been registered with ClinicalTrials.gov, a database of privately and publicly funded clinical studies conducted around the world. The ClinicalTrials.gov identifier (NCT number) for the APEX COPD Registry is NCT04285047 and further information is also listed publically on the ClinicalTrials.gov database.